A novel strategy using lipid nanoparticles to reprogram liver immunity shows promise in generating antitumor responses ...

Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today announced the enrollment of the first patient in a ...

Findings reveal macrophages' role in immune modulation through bacterial metabolites, paving the way for improved therapies for infections and inflammation.

Also, circular RNA sterile α motif domain containing 4A (circSAMD4A) is over expressed in MPP + treated SH-SY5Y cells and participates in the apoptosis and autophagy of DAn via the miR-29c-3p-mediated ...

No Apple AirPlay No USB audio input May not sound better than the Wiim Amp So when Wiim announced its follow-up — the $379 Wiim Amp Pro — with better Wi-Fi and Bluetooth, improved audio ...

Get Instant Summarized Text (Gist) A computational tool named NuFold has been developed to model 3D RNA structures, potentially accelerating medical discoveries by decades. This tool addresses the ...

This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer ...

WiiM has teased a new device at the Bristol Hi-Fi Show, and it's a little different from its other products. The WiiM Vibelink Amp is the firm's first amp without any streaming smarts. There's no ...

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

What is the current share price of AMP Limited (AMP)? AMP Limited's (AMP) current share price is $1.29. This constitutes a price movement of 5.17% when compared to the share price 7 days ago and is ...